Oral anticoagulants are associated with a significant reduction in dementia risk for atrial fibrillation patients.
Christine Blank, Contributing Editor
A new resource for patients with deep vein thrombosis aims to educate about interventional therapies.
Three pharmacists were caught trying to access the deceased star’s records just days after his death.
A change in reimbursement policy for biosimilar drugs could save CMS billions.
The FDA has issued draft guidances that should ease the way for more generic drugs.
The risk of intraocular bleeding was reduced by one-fifth when using newer anticoagulants versus warfarin in a new study.
Dual antithrombotic therapy using dabigatran significantly reduces risk of bleeding compared to triple therapy using warfarin.
A California bill aimed at curbing drug prices is about to be signed, despite concerns it will raise generic drug prices.
CVS Health executives are pleased that a lawsuit alleging collusion with PBMS on generic drug costs has been withdrawn.
Rivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.